Final Medicare Physician Fee Schedule Rule Released for CY 2023

The Centers for Medicare and Medicaid Services (CMS) published the Medicare Physician Fee Schedule (MPFS) for calendar year (CY) 2023 in the Federal Register on November 18, 2022. Some of the key provisions contained in the final rule include (and are effective January 1, 2023):

Medicare Telehealth Services

  • Added new HCPCS codes to Medicare’s list of Category 1-based telehealth services.
  • Implementation of 151-day extensions of Medicare telehealth flexibilities, including allowing telehealth services to be provided in any geographic area and any source location.
  • Permission for physical therapists, occupational therapists, speech therapists and speech therapists to provide telehealth services.
  • The list of codes added to the list of telehealth services is here.

Assessment and Management Visits (E&M)

  • For CY 2023, CMS finalized changes to “Other E/M” visits that parallel the changes made in recent years to coding and payment for office/outpatient E/M visits. Other E/M visits include hospital admission, hospital observation, emergency room, ward, home services, residency services, and assessment visits for cognitive impairment.

behavioral health

  • Finalized proposal to create a new HCPCS code (G0323) describing General Behavioral Health Integration undertaken by clinical psychologists or clinical social workers to account for monthly care integration where the mental health services provided are serving as the focal point of care integration .

Chronic pain treatment

  • Finalized a CY 2023 proposal to create two new G-codes (G3002 and G3003) executed by physicians and other qualified healthcare professionals describing monthly CPM for payment beginning January 1, 2023.

Opioid treatment programs (OTPs)

  • CMS has finalized the proposal to allow for OTP supplemental intake code provided via interactive two-way audio and video technology when charging for initiation of buprenorphine treatment using audio and video technology to initiate buprenorphine treatment as authorized by the Drug Enforcement Administration (DEA) and Substance Abuse and Mental Health Services Administration (SAMHSA) at the time the service is provided.
  • CMS also finalized the proposal to allow the use of two-way, interactive, audio-only technology to initiate buprenorphine treatment in cases where audio and video technology is not available to the patient and all other applicable requirements are met. attended.

Melissa Dehoff is responsible for all medical rehabilitation and brain injury service issues. Mrs. Dehoff participates in various state meetings to advocate on behalf of members on brain injury and rehabilitation issues and is a member of the Department of Health’s Traumatic Brain Injury Advisory Board.

Final Medicare Physician Fee Schedule Rule Released for CY 2023

Leave a Reply

Your email address will not be published.

Scroll to top